chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 8PM (so roughly 8,5 hours) after the 2nd Pfizer dose, I started to experience chills, body aches, and a fever. It kept me up all night. At 7AM, I had 100.4 degree fever and took a 500 mg Tylenol and the symptoms subsided for about 5 hours. Around 12PM, had chills again and fever and took another 500 mg Tylenol.  Fever went up to 101 at 7PM (almost 24 hours since first onset) and took another 500 mg Tylenol. Since Sunday night, I have been waking up in the middle of the night with weird, vivid dreams/images. The other symptoms don't worry me but this certainly does. The first night (Sunday) I woke up at 2AM and last night 12:50AM. I am hoping it doesn't continue but I have not done anything differently since the second Pfizer vaccine. No added stress nothing.
Pt experience severe headache, hypertension, head pressure, muscle twitching of the face, numbness on the right side of the head-temporal area, shortness of breath and left sided chest pressure
Given in the left arm. Very sore upper arm and shoulder. Swollen, hot, red. Lasted for 4 days. On the 4th day left arm started to ache felt like a tightness around upper arm. Arm constantly hurts. Nothing I take relieved the ache.
This spontaneous report as received from a certified medical assistant (healthcare worker) refers to an unspecified number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with doses of MMR II, 0.5 ml, subcutaneous, lot # K001231, expiration date 27-JAN-2016; lot # K002816, expiration date 25-FEB-2016 and lot # K011317, expiration date 13-AUG-2016, that were improperly stored. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Swollen raised red round area at injection site.   6.5 cm in diameter  Extremely itchy
horrible reaction for two solid days, so painful, awful, were down for the count; Was so awful; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain and feels awful. On an unknown date, the outcome of the pain and feels awful were unknown.   It was unknown if the reporter considered the pain and feels awful to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient's spouse. The age at vaccination was not reported. The patient had absolutely horrible reaction from the Shingle shot for 2 solid days and it was so painful and awful. The patient was down for the count and they need to do something about this shot. This case has been linked with case US2021AMR194173, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR194173:Same reporter, different patient (wife)
Client had itching at injection site 3-4 days and later in the week, the itching increased and was red. Had 2 blisters. Scratched 1 at injection site and the 2nd one was 1" away. Called and spoke to nurse at health dept. Used cortisone locally and it went away in "several weeks". Has occasional itching at site since then. She left message at her doctor's but did not speak to or see physician.
I have a headache, stuffy nose, fever, and fatigue. I can't taste anything. I just don't feel good. I been sneezing. On Tuesday night, I had chills. I am getting a COVID-19 test today. These symptoms started on October 31st. Today symptoms are the worse.
Narrative: COVID infection following COVID vaccine series 01/27, Pfizer, dose #1 02/18, Pfizer, dose #2 07/13 COVID swab, result: NOT detected 09/14 COVID swab, result: detected 09/13 pt cc: cough, headache, myalgias, rhinorrhea, sore throat exposure: bother COVID + 09/23 clinically resolved
Client reported being fine with first dose.  She initially felt fine, but about 5-10 minutes she started feeling itchy.  Client started with itchy tongue which progressed to her arms and legs.  Client denied chest pain, SOB nausea or vomitting,  just the itchiness.  Oral Benadryl given 25mgh/10ml at 1716pm.
4hr p/vax pt had rash ankles swollen, legs tingling, red welts/hives on whole body, gen itching improved w/DPH;still has some rash today;
Note: I have severe COPD - oxygen user. Within 24 hours, breathing was much, much worse and remains so. Upon rising the next morning and for 5 total mornings, I was so dizzy I could not stand. I've never been dizzy in my life. The dizziness stopped in about 10 minutes - very scary at my age. Nausea lasting from Oct. 1 through Oct. 23, and starting again 10-26.
ascending paresthesias, left leg weakness w/ transverse myelitis: hosp for 5 days sudomedrol. sx occurred w. 36 hr of influenza vax; no other expandable cause for sx.
arm pain; throat pain; Face Pain; Red Spots on Face; Diarrhea; chills; Swollen Lymph Nodes - in Chest/right neck lymph node pain; Bump Near Injection Site; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), OROPHARYNGEAL PAIN (throat pain), FACIAL PAIN (Face Pain), RASH ERYTHEMATOUS (Red Spots on Face) and DIARRHOEA (Diarrhea) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain), OROPHARYNGEAL PAIN (throat pain), FACIAL PAIN (Face Pain), RASH ERYTHEMATOUS (Red Spots on Face), DIARRHOEA (Diarrhea), CHILLS (chills), LYMPHADENOPATHY (Swollen Lymph Nodes - in Chest/right neck lymph node pain), INJECTION SITE MASS (Bump Near Injection Site) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (arm pain), OROPHARYNGEAL PAIN (throat pain), CHILLS (chills) and HEADACHE (headache) had resolved and FACIAL PAIN (Face Pain), RASH ERYTHEMATOUS (Red Spots on Face), DIARRHOEA (Diarrhea), LYMPHADENOPATHY (Swollen Lymph Nodes - in Chest/right neck lymph node pain) and INJECTION SITE MASS (Bump Near Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.    Most recent FOLLOW-UP information incorporated above includes: On 10-Mar-2021: follow-up received on 10-mar-2021 and Event information was updated.
ACHES EVERYWHERE; HORRIBLE CHILLS; FEVER; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced aches everywhere, horrible chills, and fever. The action taken with covid-19 vaccine was not applicable. The outcome of the fever, horrible chills and aches everywhere was not reported. This report was non-serious.
didn't feel that great/she felt like she needed to go to bed and didn't feel that great/She stayed in bed for a couple of days, and felt like she had a cold; covid 19; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (didn't feel that great/she felt like she needed to go to bed and didn't feel that great/She stayed in bed for a couple of days, and felt like she had a cold) and COVID-19 (covid 19) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045J21A, 039A21A and 021C21A) for COVID-19 prophylaxis.     No medical history information was reported by the reporter.  Concomitant products included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (TDAP) and INFLUENZA VACCINE (FLU VACCINE VII) for an unknown indication.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (didn't feel that great/she felt like she needed to go to bed and didn't feel that great/She stayed in bed for a couple of days, and felt like she had a cold) and COVID-19 (covid 19). At the time of the report, FEELING ABNORMAL (didn't feel that great/she felt like she needed to go to bed and didn't feel that great/She stayed in bed for a couple of days, and felt like she had a cold) outcome was unknown and COVID-19 (covid 19) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient had COVID on 26-DEC. Treatment details was not reported by the reporter.
Patient called to report redness around the area of the injection.  It is not sore, itchy or bothersome.  She is not sure how long it has been there as she just noticed it today and immunization was a week ago.  I counseled the patient to keep and eye on the area and report back if the red area gets larger or bothersome to her.
Patient experienced hallucinations approximately 15 minutes after administration of vaccination. Per patient she was disoriented, felt feverish, and had pain to back and shoulders. She stated that she was experiencing strange thoughts and felt as if she was delusional. She drove herself home and continued to feel "not right". She did not call to report or go to the ER or Urgent Care. Instead she went to bed and slept for 12 hours. When she awoke she was no longer experiencing strange thoughts. However, she continues to complain of back/shoulder pain.
Heart rate 8 hour later was 150 - 160bpm, an hour later it was down to 80pbm (normal).
PT'S BLOOD TEST HBSAG POS AT BLOOD BANK.  CONFIRMATORY RESULTS REC'D 5-11-90.  PT REC'D ENGEREX-B THRU EMPLOYER; HX OF HAVING HEPATITIS BUT UNKNOWN TYPE
This case was reported by a pharmacist via sales rep and described the occurrence of calcium in a 76-year-old male patient who received SHINGRIX (batch number YS53Y, expiry date unknown) and (batch number 52G7X, expiry date unknown). On 2nd February 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, the dose was an unknown dose. On an unknown date, less than a week after receiving SHINGRIX, the patient experienced calcium deposits, shoulder pain and mobility decreased. On an unknown date, the outcome of the calcium deposits was unknown and the outcome of the shoulder pain and mobility decreased were recovered/resolved. It was unknown if the reporter considered the calcium deposits, shoulder pain and mobility decreased to be related to SHINGRIX. Additional information was reported as follows: Within a few days after vaccination the patient developed pain and then difficulty with movement. The pain lasted about 3 weeks and the difficulty with movement lasted another 3 weeks. An X-ray of the shoulder was taken at some point and showed calcification. The batch number for SHINGRIX was updated from YS534 to YS53Y as per sales data sheet.
pt recvd vax w/face all swollen & eyes puffy almost closed; mild fever & some nasal congestion; No swelling or redness @ inject site; no breathing difficulty or rash noted;
This case was reported by a physician, via a GSK representative, and described the occurrence of high fever in an infant male subject who was vaccinated with PEDIARIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of PEDIARIX (.5 ml, unknown route and site). On an unspecified date in either August or September 2013, at an unspecified time after vaccination with PEDIARIX, the subject experienced high fever. The physician reported that the subject was taken to the Emergency Room "multiple" times for the high fever. At the time of reporting the event was resolved. The physician considered the event was probably related to vaccination with PEDIARIX. The physician also reported that multiple subjects had reported fever following vaccination with PEDIARIX. See case ID A1042995A for details.
fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue). At the time of the report, FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       relevant concomitant products usage were not reported by the reporter. Treatment details not included.   This case was linked to MOD-2021-058648 (Patient Link).
TWENTY MINUTES AFTER RECEIVING IMMUNIZATIONS WAS TAKEN FROM CLASSROOM TO THE SCHOOL NURSE COMPLAINING OF A LITTLE HEADACHE AND DIZZINESS. BP=100/58. NO SHORTNESS OF BREATH OR DIAPHORESIS.HAD PATIENT LYING DOWN ON TABLE IN THE NURSE'S OFFICE. STATED SHE FELT A LITTLE BETTER. GIVEN WATER AND MOTHER CALLED. MOTHER CAME AND TOOK DAUGHTER HOME. PATIENT DENIES ANY BAD SYMPTOMS AFTER GETTING THE SHOTS BUT FELT BAD TWENTY MINUTES LATER AND REPORTED IT TO HER TEACHER.
tonic clonic sz 12 hr p/vax; was febrile 100.4 @ the time lasted 5 mins;
PATIENT STATES SEVERE BRUISING AROUND INJECTION SITE FOR APPROXIMATELY 5 DAYS FOLLOWING ADMINISTRATION. ALSO REPORTS SEVERE "FLU-LIKE" SYMPTOMS STARTING ABOUT ONE WEEK FOLLOWING ADMINISTRATION.
Pulmonary embolism, treated at the Brigham and Women's Hospital 2/19/09-records received for DOS 5/6-5/9/09-DC DX:Pulmonary embolism. Presented with sort of breath pleuritic chest pain. PEinvolving distal right and left main PAs with RV dilation.
Fever; rash all over the body; pain at injection site; arm was swollen; arm was red; feeling chills; left arm hot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (left arm hot), RASH (rash all over the body), VACCINATION SITE PAIN (pain at injection site), VACCINATION SITE SWELLING (arm was swollen) and VACCINATION SITE ERYTHEMA (arm was red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy (Multiple unspecified allergies).  On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 04-Feb-2021, the patient experienced VACCINATION SITE WARMTH (left arm hot). On 04-Mar-2021, the patient experienced RASH (rash all over the body), VACCINATION SITE PAIN (pain at injection site), VACCINATION SITE SWELLING (arm was swollen), VACCINATION SITE ERYTHEMA (arm was red) and CHILLS (feeling chills).   On 05-Mar-2021, the patient experienced PYREXIA (Fever). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) for Allergy, at an unspecified dose and frequency.   At the time of the report, VACCINATION SITE WARMTH (left arm hot), RASH (rash all over the body), VACCINATION SITE PAIN (pain at injection site), VACCINATION SITE SWELLING (arm was swollen), VACCINATION SITE ERYTHEMA (arm was red), CHILLS (feeling chills) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Body temperature: 100 (High) 100 degrees Fahrenheit.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications were not reported.
Chest pressure and tightness. Dry cough. Back pain. Insomnia.
Patient reported shortness of breath, chest tightness, and difficulty taking a breath after she received her Moderna booster. Husband called paramedics over to assess patient and she stated when she opened the window she started to feel better. At 4:19 pm her vitals were as follows: BP 128/78, 61 heart rate, respirations 18, SPO2 18. Patient sitting in passenger seat, able to speak full sentences and drink water without difficulty. No dizziness or numbness and tingling reported. Patient did not need any further observation and left with no symptoms.
My period (which has been perfectly regular for over 2 years, and I track very closely) was about 8 days late.
Flu vaccine 10-14-09 evening. LEXAPRO taken 10-15-09 for first time *swollen upper lip; body itchiness since am 10-15-09 **given PREDISONE 10 mg
Febrile, erythema @ injection site, rash spread from site down to elbow on Left arm - Sx onset 10/7/09. Temp 99.9.
hot; Hard; Itching; Swollen; Redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot), VACCINATION SITE INDURATION (Hard), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE ERYTHEMA (Redness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic kidney disease stage 3 (stage 3). Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR), NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), LOSARTAN, FENOFIBRATE, FUROSEMIDE (LASIX [FUROSEMIDE]), MULTIVITAMIN [VITAMINS NOS], COLECALCIFEROL (VITAMIN D 3) and ZINC for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot), VACCINATION SITE INDURATION (Hard), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE ERYTHEMA (Redness). At the time of the report, VACCINATION SITE WARMTH (hot), VACCINATION SITE INDURATION (Hard), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No treatment information was provided.  On 31 Jan 2021, the patient experienced the events itching, redness, swollen, hot, and hard. On 1 Feb 2021, the patient experienced increase to the size of an orange.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Felt sick; Had a horrible neck pain; Chills; Vomiting; Fever; Felt down for two days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Felt down for two days), ILLNESS (Felt sick), NECK PAIN (Had a horrible neck pain), CHILLS (Chills) and VOMITING (Vomiting) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Felt down for two days), ILLNESS (Felt sick), NECK PAIN (Had a horrible neck pain), CHILLS (Chills), VOMITING (Vomiting) and PYREXIA (Fever). The patient was treated with HYDROCODONE for Neck pain, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (Felt down for two days), ILLNESS (Felt sick), NECK PAIN (Had a horrible neck pain), CHILLS (Chills), VOMITING (Vomiting) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Follow-up received and No New Information.
Rapid heart beat.  Onset approx 2-4 days after injection.  Slowly became better as each day passed until it was gone completely.  Until 2nd dose.  Sought ER treatment after 2nd dose because rapid heartbeat was much worse.
Tightness on the chest Blood Pressure was high 185 or 198 Dry Mouth  Hard time to breath  After 1 hour I started itching
This report is regarding the Pfizer COVID-19 vaccination you received on the above date, which was lot number FD0809. The Public Health District, per guidance from the Department of Health (DH), Centers for Disease Control and Preventio (CDC), and Pfizer have determined that the dose of vaccine that you received is valid.
MODERNA COVID-19 VACCINE EUA On February 10, 8 days after vaccine, Soreness and warmth on site of injection,  red blotches appeared, turning the next day (February 11)into an overall larger red tender area on the left arm.  On-line this was described as Covid arm.
Soreness and swelling around site, itchiness around vaccination site. Complained sl oral sores, chest pain and longitude, fatigue and lymphadenopathy in 11/28th and then rash on both legs. She complained of scattered non painful lesions on her back and neck.
Caller is nurse reporting a patient experienced localized swelling around injection site after receiving GARDASIL 9./It was just swollen, not red or warm.; This spontaneous report was received from a nurse and refers to a 14-year-old, non-pregnant female patient. She had no known drug reactions or allergies, nor pertinent medical history. There were no concomitant medication.  On an unknown date, the patient received the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9)(exact dose, injection site, lot#, expiration date and route of administration were not provided) for prophylaxis. On 17-AUG-2022, the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) prefilled syringe injection, 1 dose, lot # 1780876, expiration date: 09-NOV-2023, intramuscularly in the left deltoid for prophylaxis(exact dose, dosing schedule were not provided).  On 18-AUG-2022, the patient experienced localized swelling around injection site, which looked like "she had a second muscle" (vaccination site swelling). According to nurse it was just swollen, not red or warm. On the same day, the patient sought medical attention and called the office to report. On 19-AUG-2022 (also reported as today), she was seen by her provider for assessment. The only intervention was ibuprofen administered as needed for the treatment of the event. The patient denied a reaction with the first dose. No additional adverse events reported.  At the time of reporting, the patient had not recovered from vaccination site swelling. The causality assessment between the suspect vaccines and the event was not provided.
NEAR SYNCOPE, DIAPHORETIC, VOMITING, BRADYCARIA
On 2nd day after injection noticed tenderness/swelling in left axillary area which progressed to swelling above the clavicle on the left side. On May 31st went to Urgent Care where dx was lymph node swelling probably due to my Covid injection 5 days earlier. Was told to return for imaging of the area if swelling had not subsided in 2 weeks.
Redness with well-defined borders, swelling, and pain upon movement and when pressure is applied to the injection site, all persisting to date (since 10/29/21)
Left upper arm swollen and warm to touch. Area that is swollen is from upper arm down to elbow area.  Benadryl suspension every 6 hours, PRN and motrin advised